Review Article
Role of Dynamic Susceptibility Contrast Perfusion MRI in Glioma Progression Evaluation
Table 3
ROC curve analyses of diagnostic performance of various variables and their combinations.
| Characteristics | AUC | 95%CI | Sensitivity | Specificity | Youden index |
| CE | 0.782 | 0.643–0.920 | 0.765 | 0.786 | 0.551 | MRS | 0.881 | 0.788–0.973 | 0.882 | 0.786 | 0.668 | DSC | 0.912 | 0.837–0.988 | 0.765 | 0.929 | 0.694 | CE + MRS | 0.930 | 0.867–0.993 | 0.882 | 0.857 | 0.739 | CE + DSC | 0.936 | 0.873–0.998 | 0.863 | 0.857 | 0.720 | DSC + MRS | 0.965 | 0.924–1.000 | 0.863 | 1.000 | 0.863 | CE + MRS + DSC | 0.965 | 0.923–1.000 | 0.902 | 1.000 | 0.902 |
|
|
CE, contrast enhancement pattern of residual cavity wall; MRS, Cho/Cr and Cho/NAA ratios; DSC, dynamic susceptibility contrast perfusion.
|